Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Leukemia/Lymphoma/Myeloma

  • You have access
    FDG PET/CT for prognostic stratification of patients with nodal peripheral T cell lymphoma.
    Woo Hee Choi, Eun Ji Han, Joo Hyun O and Seok-Goo Cho
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1687;
  • You have access
    A clinical study of baseline PET/CT parameters in the prediction of refractory/ relapsed diffuse large B cell lymphoma of advanced stage patients
    Hebei Li and Qian Wang
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1685;
  • You have access
    Value of interim FDG PET/CT for monitoring response to therapy and predicting prognosis in Hodgkin’s lymphoma treated with ABVD chemotherapy
    Farah Anwer, Qaid Ahmad Shagera, Malik Juweid, Ayser Khalaf, Mohammad Ma’koseh and Akram Al-Ibraeem
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1682;
  • You have access
    Parameters on interim 18F-FDG PET are strong predictors of survival, independent of clinical prognostic indexes and biological markers, in patients with diffuse large B cell lymphoma
    Sze Ting Lee, Shin Hnin Wai, Edward Shen, Joel Wight, Tineke Fancourt, Sam Berlangieri, Andrew Scott, Eliza Hawkes and Chong Geoff
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 176;
  • You have access
    Comparison of 68Ga-Pentixafor PET-CT versus 18F-FDG PET-CT in staging of multiple myeloma
    Baljinder Singh, Amit Shekhawat, Pankaj Malhotra, Rajender Kumar, Ankit Watts, Harmandeep Singh, Harneet Kaur and Bishan Radotra
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 171;
  • You have access
    Clinical detection of systemic amyloidosis by PET/CT imaging using 124I-p5+14 peptide
    Jonathan Wall, Emily Martin, Alan Stuckey, Tina Richey, Angela Williams, Craig Wooliver, Sallie Macy, James Foster, Bryan Whittle, Robin Geldrich, Mark Powell, Yitong Fu, Dustin Powell, Dustin Osborne, Robert Heidel, Barbara Marine, Myrwood Besozzi, Radhakrishnan Ramchandren, Ronald Lands and Stephen Kennel
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 172;
  • You have access
    18F-FDG PET/CT imaging findings in Erdheim-Chester Disease
    Na Niu, Qiao Yang and Fang Li
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 170;
  • You have access
    Imaging of chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in lymphoma: comparison to 18F-FDG
    Qingqing Pan, Yaping Luo, Xinxin Cao and Fang Li
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 167;
  • You have access
    Clinical Utility of 18F-FDG PET/CT in Adult Langerhans Cell Histiocytosis: An analysis of 57 Patients
    Meiqi Wu, Na Niu and Li Huo
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 169;
  • You have access
    Can pre-treatment 18F-FDG PET/CT predict prognosis of extranodal natural killer/T-cell lymphoma?
    Rui Guo, Hongping Meng and Biao Li
    Journal of Nuclear Medicine May 1, 2020, 61 (supplement 1) 173;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire